Vascular Access Device Market - Global Industry Analysis and Forecast(2025-2032)

Vascular Access Device Market Overview

The vascular access device industry is on a high growth trajectory, having evolved significantly in the last decade. The sector has grown considerably during recent period and plays a important role at each stage of the healthcare continuum. It has been instrumental in improving access and affordability of healthcare services. The current demand and supply side dynamics provide a significant opportunity and rationale for manufacturing vascular access devices globally. The Government initiative presents a platform for the sector to revisit the operating model, identify key imperatives for growth and explore possibilities for creating a step change in the vascular access devices sector.

 

Heart disease remains the leading cause of death worldwide, with one person dying every 33 seconds from cardiovascular disease. In 2022 alone, heart disease accounted for 702,880 deaths in the U.S., representing 1 in every 5 fatalities. The economic burden is also significant, costing approximately $252.2 billion from 2019 to 2020, including healthcare services, medications, and lost productivity. This growing prevalence of cardiovascular conditions directly impacts the vascular access device market, as patients with heart disease often require long-term intravenous therapies, catheterization procedures, and hemodynamic monitoring. The increasing need for percutaneous coronary interventions (PCI), intravenous drug administration, and emergency interventions highlights the demand for advanced vascular access solutions, such as central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and arterial lines. Additionally, advancements in minimally invasive vascular access technologies play a crucial role in improving patient outcomes, reducing complications, and enhancing procedural efficiency for cardiovascular treatments. As heart disease continues to rise, the vascular access device market is expected to expand, driven by innovations in infection control, catheter design, and long-term vascular access management.

 

The rising prevalence of chronic kidney disease (CKD) and ESKD, necessitating reliable vascular access solutions to ensure seamless haemodialysis treatments. Innovations in vascular access devices, including high-pressure balloons, stent grafts, thrombectomy devices, and percutaneous arteriovenous fistula (pAVF) creation, have significantly improved patient outcomes by reducing complications such as stenosis, thrombosis, and infection risks. Additionally, the shift from surgical to endovascular procedures has increased the adoption of catheter-based interventions, expanding treatment options for patients with complex vascular access needs. The growing emphasis on multidisciplinary collaboration among nephrologists, vascular surgeons, and interventional radiologists further strengthens the vascular access device industry, enhancing personalized treatment strategies, early intervention approaches, and evidence-based clinical practices. Moreover, increasing training programs and educational initiatives are influential in healthcare professionals' expertise in DVA management, driving innovation in Vascular Access Device Market. With an aging population, expanding dialysis patient pool, and continuous advancements in vascular access devices, continue to grow, ensuring improved long-term access functionality, patient safety, and quality of life.

 

 

To get more Insights: Request Free Sample Report

 

Vascular Access Device Market Dynamics:

Demand Side Driving Factors:

The vascular access device industry is the increasing incidence of chronic diseases such as cancer, kidney disease, and cardiovascular disorders. These conditions often require long-term intravenous (IV) therapies, making VADs essential for continuous medication delivery. The growing burden of chronic illnesses has led to an increased demand for reliable and long-term vascular access solutions. Chronic diseases, including cardiovascular diseases, cancer, diabetes, and respiratory illnesses, are projected to account for 86% of the 90 million annual deaths, marking a staggering 90% increase in absolute numbers since 2019 which boost Vascular Access Device Industry.

 

Infiltration and extravasation not only pose significant clinical risks but also contribute to a considerable economic burden, as evidenced by data from the U.K., U.S., Australia, and China. In the U.K., a report from NHS Resolution revealed that between 2010 and 2021, claims related to extravasation injuries cost the National Health Service (NHS) USD 16 million, including legal fees and damages. Similarly, in the U.S., claims data comparing patients with and without peripheral intravenous catheter (PIVC) complications, including extravasation, showed a substantial difference in hospitalization costs, with affected patients incurring an average cost of $10,895 compared to $7,009 for those without complications. These financial implications highlight the need for improved vascular access device technologies, better insertion techniques, and enhanced surveillance strategies to minimize complications, improve patient outcomes, and reduce the overall healthcare burden.

 

The aging population is major factor contributing to the expansion of the vascular access device market. Older adults are more susceptible to chronic illnesses that necessitate frequent hospitalization and long-term IV therapy. This demographic shift is increasing the demand for safe, efficient, and durable VADs that can cater to their healthcare needs. By 2050, 80% of the elderly population will reside in low- and middle-income countries, increasing the demand for affordable and accessible vascular access solutions. The pace of population aging is accelerating faster than ever before, with the number of people aged 60 years and older surpassing children under five in 2020. Additionally, between 2015 and 2050, the proportion of the global population over 60 years will nearly double from 12% to 22%, driving the need for advanced, long-term vascular access devices that enhance patient comfort and reduce complications. This demographic shift underscores the growing importance of innovative VADs in managing age-related health conditions efficiently. These factors drives the Vascular Access Device Market growth.

 

Technological Advancements and Product Innovations

Innovative advancements in catheter technology are enhancing both therapeutic and diagnostic applications, with a focus on improving performance characteristics. Coil and braid reinforcement is widely utilized to achieve ultra-thin walled tubing, reduced shaft profiles, improved flexibility, enhanced kink resistance, and superior torque control. Additionally, the development of metal shafts and hypotubes is driving innovation in PTCA catheters, intravascular imaging devices, and other specialized catheter solutions. The use of wire and coil-based delivery systems and guidewires is also playing a crucial role in both neurovascular and cardiovascular procedures. Custom extrusion solutions are being developed with precise tolerance requirements and minimal wall thickness, ensuring optimal functionality for catheter devices.

 

The advancement of balloon catheters is key area of innovation, with a focus on achieving precise tolerances and optimal performance levels. Extensive expertise in working with non-compliant, semi-compliant, and compliant materials has enabled the successful development of balloons for both PTCA and PTA applications. The expertise in molding and insert molding is supporting the production of critical catheter components, including catheter tips, bifurcated and mono luers, rapid exchange joints, multi-lumen joiners, multi-exchange joints, Y-connectors, and strain reliefs. In addition to these components, design, development, and manufacturing capabilities extend to the production of deployment handles and assemblies, ensuring a comprehensive approach to catheter device innovation, which Propel the Vascular Access Device Market.

 

 

Increasing Demand for Home Healthcare Services

The rising preference for home-based care, there is a growing demand for vascular access devices that enable patients to receive IV therapy outside hospital settings. Home healthcare services are particularly popular among cancer, diabetes, and chronic kidney disease patients, who require long-term treatment but prefer to avoid frequent hospital visits. The COVID-19 pandemic further accelerated this trend as hospitals sought to minimize patient exposure by shifting treatment settings to homes or outpatient clinics. This shift is creating significant market opportunities for portable, easy-to-use vascular access devices that cater to home-based therapy needs.

 

Value Pool Initiative Outcomes in Home Healthcare

Country	Initiative	Key Outcomes	Value Drivers
USA	Hospital at Home (Johns Hopkins)	Acute-care delivery at home based on physician recommendation	32% cost reduction and 33.33% reduction in average length of stay (ALOS) for home care instead of hospitalization.
Japan	Long-Term Care Insurance (LTCI)	Government-backed funding for geriatric home care	86% positive feedback, 52% increase in adoption in year one, 82% increase in year two, 2 million jobs created, 100% rise in home care beneficiaries within a decade, 82% decline in hospital bed days.
Canada	Ramnow Commission Home Care Initiative	Recognized home care as essential for an aging population	Addresses 77% of elderly population with chronic illnesses, increasing accessibility and reducing hospital burden.
Denmark	Large-scale Telehealth for COPD Patients	Remote monitoring and care delivery	Auto-generated diagnostic reports, remote patient monitoring, home-based nursing care, personalized diet and rehabilitation.
Iceland	Interconnected Health Information Exchange System	Secure, real-time health data exchange for seamless clinical support	Patient lifestyle changes updated on mobile apps, enabling real-time management of medications and care aspects.
Sweden	Smart Wearables for Atrial Fibrillation Detection	Empowering citizens to monitor heart health	Preemptive and preventive care, real-time health monitoring, and personalized ambulatory services on demand.
Norway	Dementia-Friendly Society with Tech Support	Technology-enabled home care for dementia patients	Surveillance systems for emergency support, medication reminders, telemedicine on demand, electronic patient journal using IoT for real-time monitoring.

 

Advancements in Wearable and Smart Vascular Access Devices

The integration of digital health technologies with vascular access devices is an emerging trend. Smart VADs equipped with sensors, wireless connectivity, and remote monitoring capabilities are transforming patient care. These innovations provide real-time data on catheter function, infection risk, and medication administration, allowing healthcare providers to monitor patients remotely.

• On November 30, 2023, BD (Becton, Dickinson and Company) launched the SiteRite 9 Ultrasound System, an advanced vascular access ultrasound designed to enhance clinician efficiency in placing PICCs, central venous catheters, and IV lines. Featuring a 15.6-inch touchscreen, enhanced image quality, and smart vessel assessment tools, it integrates the Cue Needle Tracking System and Sherlock 3CG+ Tip Confirmation System for real-time navigation. This innovation supports BD’s "One-Stick Hospital Stay" vision, reducing multiple needlesticks and improving first-attempt success rates. SiteRite™ 9 received 510(k) clearance in September 2023.

 

Company	Description
Boston Scientific Corporation	Produces a wide End-User of medical devices, including diagnostic catheters for various medical procedures.
Medtronic	A major player in the medical device industry, offering diagnostic catheters among its extensive portfolio of medical devices and technologies.
Abbott Laboratories	A global healthcare company that produces various medical devices, including diagnostic catheters used in cardiovascular procedures.
Johnson & Johnson	Develops and manufactures diagnostic catheters for cardiac and vascular interventions through its subsidiary Cordis.
Terumo Corporation	A Japanese multinational medical devices and equipment company known for its diagnostic catheters used in cardiology and radiology.
B. Braun Melsungen AG	A German medical and pharmaceutical company that manufactures diagnostic catheters along with a wide End-User of medical products.
Merit Medical Systems, Inc.	A leading manufacturer and distributor of medical devices, including diagnostic and interventional catheters.
Cook Medical	A family-owned medical device company that produces diagnostic catheters for various medical specialties, including cardiology and radiology.

Table: Diagnostics Catheter Key Players

 

Challenges of PIVC Longevity:

Vascular access device insertion is one of the most frequently performed invasive procedures in healthcare settings. These devices are essential for delivering medications, fluids, and nutrients to patients who require intravenous therapy. However, despite their widespread use, vascular access devices pose significant challenges related to patient safety, infection control, and device longevity.

 

Central vascular access devices (CVADs) and peripheral intravenous catheters (PIVCs) serve different purposes in clinical care. CVADs are commonly used for patients requiring extended and repeated access, administration of irritant or vesicant drugs, and those with poor peripheral venous access. On the other hand, PIVCs are widely used for intravenous therapy, hydration, and medication administration. More than 400 million PIVCs are sold annually in the U.S., with up to 90% of hospitalized patients receiving one during their stay. Despite their frequent use, up to 50% of PIVCs require replacement before the completion of therapy, adding to patient discomfort and healthcare costs.

 

Similarly, central lines, critical for long-term treatment, come with complications. More than 4 million CVADs are sold in the U.S. each year, yet up to 25% of central lines in pediatric patients must be removed before therapy completion. One of the most concerning risks  associated with vascular access devices is infection. PIVCs contribute to an estimated one in three healthcare-associated Staphylococcus aureus catheter-related bloodstream infections (CRBSIs). Additionally, central line-associated bloodstream infections (CLABSIs) are a major concern, with up to one in four patients who acquire a CLABSI dying as a result. Upto 82 patients acquire a CLABSI every day, highlighting the urgent need for improved infection prevention strategies and safer vascular access solutions hampered the Vascular Access Device Market.

 

Vascular Access Device Market Segment Analysis:

Based on Product Type: the market is segmented into Short PIVCs (Peripheral Intravenous Catheters), Huber Needles, Midline Catheters, PICCs (Peripherally Inserted Central Catheters), CVCs (Central Venous Catheters), and Others. Short PIVCs (Peripheral Intravenous Catheters) witnessed highest market share in 2024 and continued its dominance during the forecast period. Short Peripheral Intravenous Catheters (PIVCs) dominate the Vascular Access Device Market due to their widespread use in hospitals, clinics, and emergency settings. These catheters are the most commonly used vascular access devices, enabling efficient administration of medications, fluids, and blood products. Their ease of insertion, low cost, and versatility make them the preferred choice for short-term intravenous therapy, driving their market dominance.

 

The increasing prevalence of chronic diseases, rising hospital admissions, and growing surgical procedures further contribute to the high demand for Short PIVCs. Additionally, advancements in catheter technology, such as antimicrobial coatings and safety features to reduce needlestick injuries and infections, enhance their adoption in healthcare settings. Moreover, the preference for minimally invasive procedures and the focus on reducing patient discomfort promote the use of Short PIVCs. Healthcare providers favor them due to their high success rate, reduced complications, and ability to provide immediate vascular access. As the global healthcare landscape evolves, the demand for Short PIVCs is expected to grow, particularly in developing regions where healthcare infrastructure is expanding. Their cost-effectiveness, safety improvements, and clinical efficiency solidify their position as the leading vascular access device in the market.

 

 

Vascular Access Device Market Regional Analysis:

North America witnessed the highest market share in the Vascular Access Device Market growth in 2024 and is expected to maintain its dominance throughout the forecast period. The region’s leadership is attributed to the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and kidney diseases, which require long-term intravenous therapy and vascular access devices. Additionally, the growing geriatric population and rising hospital admissions have further fueled demand for these devices. The presence of advanced healthcare infrastructure, high healthcare expenditure, and rapid adoption of innovative medical technologies have positioned North America as a key market player in United . The region has witnessed significant advancements in vascular access technologies, such as ultrasound-guided catheter placement, antimicrobial-coated catheters, and bioabsorbable materials, which have improved patient safety and device longevity.

 

 

 

The U.S. FDA authorized marketing for the Ellipsys Vascular Access System and everlinQ endoAVF System to create arteriovenous (AV) fistulas for hemodialysis patients with chronic kidney disease. Traditionally, AV fistulas require surgery, but these catheter-based devices enable a less-invasive, percutaneous approach.

• On November 19, 2024, Xeltis declared the FDA granted Breakthrough Device designation for its aXess vascular access conduit and enrolled the first patient in its U.S. pivotal trial. The aXess device is designed to create a permanent, living vessel for hemodialysis access. The first patient was treated by Dr. Karl Illig at the Flow Vascular Institute in Houston, Texas. The trial is led by National Principal Investigator Dr. John Lucas III. Xeltis aims to reduce reinterventions and infections associated with current vascular access options, offering a groundbreaking advancement in the field. The pivotal trial follows FDA IDE approval in June 2024.

 

Competitive landscape

The vascular access device market is driven by key players offering innovative solutions for patient care. Leading companies include B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), and Terumo Corporation (Japan). U.S. giants such as Becton, Dickinson and Company (BD), Medtronic, Edwards Lifesciences, and Baxter International contribute significantly. ICU Medical, Teleflex, AngioDynamics, and Cook Medical provide specialized vascular access technologies. Global leaders like Fresenius Medical Care, Siemens Healthineers, and Philips Healthcare enhance market growth with advanced solutions. 3M Health Care, Cardinal Health, Boston Scientific, and Abbott Laboratories also play vital roles, ensuring continuous innovation and improved vascular access care worldwide.

 

 

Vascular Access Device Market Scope
Market Size in 2024	USD 4.89 Billion
Market Size in 2032	USD 8.18 Billion
CAGR (2024-2032)	6.64%
Historic Data	2019-2024
Base Year	2024
Forecast Period	2025-2032
Segments	By Product Type Short PIVCs (Peripheral Intravenous Catheters) Huber Needles Midline Catheters PICCs(Peripherally Inserted Central Catheters) CVCs (Central Venous Catheters) Others
	By End User Hospitals Ambulatory care centers Clinics Others
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Vietnam, Taiwan, and Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Chile, Peru, Rest of South America

 

Vascular Access Device Market Key Players:

1. B. Braun Melsungen AG (Melsungen, Germany)
2. Coloplast A/S (Humlebæk, Denmark)
3. UFP Technologies, Inc. (Newburyport, Massachusetts, USA)
4. Edwards Lifesciences Corporation (Irvine, California, USA)
5. Medtronic plc (Galway, Ireland)
6. Becton, Dickinson and Company (BD) (Franklin Lakes, New Jersey, USA)
7. Teleflex Incorporated (Wayne, Pennsylvania, USA)
8. AngioDynamics, Inc. (Latham, New York, USA)
9. Terumo Corporation (Tokyo, Japan)
10. Smiths Medical (Minneapolis, Minnesota, USA)
11. Nipro Corporation (Osaka, Japan)
12. Cook Medical (Bloomington, Indiana, USA)
13. Vygon Group (Écouen, France)
14. Fresenius Medical Care AG & Co. KGaA (Bad Homburg, Germany)
15. ICU Medical, Inc. (San Clemente, California, USA)
16. Baxter International Inc. (Deerfield, Illinois, USA)
17. Cardinal Health, Inc. (Dublin, Ohio, USA)
18. 3M Health Care (Saint Paul, Minnesota, USA)
19. Boston Scientific Corporation (Marlborough, Massachusetts, USA)
20. Abbott Laboratories (Abbott Park, Illinois, USA)
21. Stryker Corporation (Kalamazoo, Michigan, USA)
22. Johnson & Johnson (New Brunswick, New Jersey, USA)
23. Siemens Healthineers AG (Erlangen, Germany)
24. GE Healthcare (Chicago, Illinois, USA)
25. Philips Healthcare (Amsterdam, Netherlands)